Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVolex Regulatory News (VLX)

Share Price Information for Volex (VLX)

Share Price is delayed by 15 minutes
Get Live Data
587.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 5.00 (0.861%)
Market Cap: £1.08b
VLX Live PriceLast checked at - London Stock Exchange

Intraday Volex Share Chart

Trading Update

15 Oct 2020 07:00

RNS Number : 1183C
Volex PLC
15 October 2020
 

15 October 2020

 

Volex plc

("Volex" or the "Company")

 

Trading Update

 

Volex plc (AIM:VLX), the global supplier of integrated manufacturing services and power products, is today issuing a trading update ahead of the scheduled announcement of the group's interim results for the 26 weeks ended 4 October 2020, on 12 November 2020. 

COVID-19

 

We are continuing to monitor the global situation in respect of COVID-19. The health, safety and well-being of our colleagues remain our principal responsibility and we are providing our facilities with our full support, following all public health advice, and complying with all government directives. All manufacturing facilities remained fully operational following adaptations that were made in the first quarter in response to the COVID-19 pandemic.

 

Trading

 

Volex's performance has continued to improve since the group last updated the market at our Annual General Meeting on 30 July 2020.

 

Consequently, the board now expects revenue and profitability to be above current market expectations for both the half-year period and the full year as a whole.

 

· Unaudited revenue for the six months ended 4 October 2020 is expected to be at least $200 million, which represents an increase of 2.2 per cent over the same period a year earlier;

 

· Underlying operating profit is expected to be at least $20 million, which represents an increase of 25.8 per cent over the same period a year earlier;

 

· Net cash excluding lease liabilities as at 2 October 2020 was approximately $31 million.

 

Executive Chairman Nat Rothschild commented:

 

"We enter the final quarter of calendar 2020 in a healthy position. Our geographic and customer diversification continues to provide the business with a high degree of visibility at this time while ongoing demand for consumer electronics remains strong and the global shift to electric vehicles gathers pace.

 

Absent another widespread COVID-19 related global lockdown, given the robust performance in the first half of the year, coupled with our strong forward order book position, the board expects to see a strong performance for the year as a whole that will be above current market expectations.

 

I would like to extend my sincere thanks to the entire Volex team for their invaluable contribution to this strong performance as we look ahead to the second half of the year with cautious optimism." 

 

For further information please contact:

 

Volex plc

+44 (0)7909 995 887

Nat Rothschild, Executive Chairman

 

Daren Morris, Chief Financial Officer

 

 

Powerscourt - Media Enquiries

+44 (0)20 7250 1446

James White

 

Jack Holden

 

 

N+1 Singer - Nominated Adviser & Joint Broker

+44 (0)20 7496 3000

Shaun Dobson

 

Iqra Amin

 

 

Panmure Gordon - Joint Broker

+44 (0)20 7886 2500

Hugh Rich

 

Nick Lovering

 

 

 

NOTES TO EDITORS:

Volex plc (AIM:VLX) is a leading integrated manufacturing specialist. The Group designs and manufactures products that ensure a critical connection never fails and are used in everything from defibrillators and ventilators through to data networking equipment and vehicle telematics. Headquartered in the United Kingdom, Volex serves the needs of its blue-chip customer base from its manufacturing sites located across nine countries and three continents, employing over 6,000 people. Volex's products are sold through its own global sales force and through distributors to Original Equipment Manufacturers ('OEMs') and Electronic Manufacturing Services companies. For more information please visit www.volex.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFFEFILESSEIS
Date   Source Headline
17th Mar 20163:52 pmRNSDirector/PDMR Shareholding
26th Feb 20169:44 amRNSDirector/PDMR Shareholding
26th Feb 20167:00 amRNSTrading Statement
21st Dec 20158:00 amRNSManagement changes
27th Nov 20157:00 amRNSDirectorate Change
16th Nov 20152:46 pmRNSChange of Adviser
12th Nov 20158:00 amRNSHalf Yearly Report
11th Nov 20159:30 amRNSDirector Declaration
9th Nov 20153:37 pmRNSDirector Declaration
19th Oct 201511:41 amRNSHolding(s) in Company
15th Oct 20157:00 amRNSAppointment of Non-Executive Director
2nd Oct 20158:21 amRNSDirector/PDMR Shareholding
1st Oct 20151:11 pmRNSHolding(s) in Company
30th Sep 20157:00 amRNSDirector/PDMR Shareholding
29th Sep 20151:00 pmRNSBoard Change and Trading Update
24th Jul 201512:54 pmRNSAGM Statement
26th Jun 20157:00 amRNSAnnual Report and Notice of AGM
18th Jun 201510:18 amRNSDirector/PDMR Shareholding
11th Jun 20157:00 amRNSPreliminary results for year ended 5 April 2015
8th Jun 20159:32 amRNSDirectorate Change
26th May 201512:01 pmRNSHolding(s) in Company
15th Apr 20157:00 amRNSAppointment of Non-Executive Director
27th Mar 20157:00 amRNSTrading Update
10th Mar 201510:55 amRNSHolding(s) in Company
9th Mar 20152:30 pmRNSHolding(s) in Company
20th Feb 20153:05 pmRNSDirector/PDMR Shareholding
4th Feb 201511:02 amRNSHolding(s) in Company
4th Feb 20158:30 amRNSHolding(s) in Company
30th Dec 20147:00 amRNSDirectorate Change
19th Dec 201412:00 pmRNSDirector/PDMR Shareholding
11th Dec 20147:00 amRNSBoard Change
8th Dec 201411:48 amRNSHolding(s) in Company
14th Nov 20141:45 pmRNSHolding(s) in Company
13th Nov 20143:52 pmRNSDirector/PDMR Shareholding
13th Nov 20141:49 pmRNSDirector/PDMR Shareholding
13th Nov 20147:00 amRNSVolex plc - Half year results to 5 October 2014
31st Oct 20143:05 pmRNSHolding(s) in Company
12th Sep 20144:23 pmRNSReplacement Director/PDMR Shareholding
12th Sep 201412:33 pmRNSDirector/PDMR Shareholding
21st Aug 201411:38 amRNSHolding(s) in Company
28th Jul 201411:01 amRNSDirector/PDMR Shareholding
21st Jul 201410:17 amRNSDirector/PDMR Shareholding
18th Jul 201411:03 amRNSResult of AGM
18th Jul 20149:39 amRNSAGM Statement
15th Jul 201410:08 amRNSDirector/PDMR Shareholding
14th Jul 201411:40 amRNSHolding(s) in Company
3rd Jul 20144:47 pmRNSHolding(s) in Company
3rd Jul 20142:59 pmRNSHolding(s) in Company
1st Jul 20141:55 pmRNSResult of General Meeting
1st Jul 20147:01 amRNSPublication of Prospectus

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.